

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding autoimmune thyroid... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1776/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1776" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity.">
            <meta name="og:description" content="Read the latest article version by Sofie Bliddal, Claus Henrik Nielsen, Ulla Feldt-Rasmussen, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12459">
            <meta name="article-id" content="11535">
            <meta name="dc.title" content="Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity">
            <meta name="dc.description" content="Autoimmune thyroid disease (AITD) is often observed together with other autoimmune diseases. The coexistence of two or more autoimmune diseases in the same patient is&amp;nbsp;referred&amp;nbsp;to as polyautoimmunity, and AITD is the autoimmune disease most frequently involved. The occurrence of polyautoimmunity has led to the hypothesis that the affected patients suffer from a generalized dysregulation of their immune system. The present review summarizes recent discoveries&amp;nbsp;unravelling&amp;nbsp;the immunological mechanisms involved in autoimmunity, ranging from natural autoimmunity to disease-specific autoimmunity. Furthermore, the clinical grounds for considering AITD in a setting of polyautoimmunity are explored. A better understanding of these&amp;nbsp;may pave the way for designing new treatment modalities targeting the underlying immune dysregulation when AITD appears in the context of polyautoimmunity.">
            <meta name="dc.subject" content="Thyroid autoimmunity, polyautoimmunity, immunology, autoimmune disease, Graves' disease, Hashimoto's thyroiditis, AITD, antibodies">
            <meta name="dc.creator" content="Bliddal, Sofie">
            <meta name="dc.creator" content="Nielsen, Claus Henrik">
            <meta name="dc.creator" content="Feldt-Rasmussen, Ulla">
            <meta name="dc.date" content="2017/09/28">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11535.1">
            <meta name="dc.source" content="F1000Research 2017 6:1776">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Thyroid autoimmunity">
            <meta name="prism.keyword" content=" polyautoimmunity">
            <meta name="prism.keyword" content=" immunology">
            <meta name="prism.keyword" content=" autoimmune disease">
            <meta name="prism.keyword" content=" Graves' disease">
            <meta name="prism.keyword" content=" Hashimoto's thyroiditis">
            <meta name="prism.keyword" content=" AITD">
            <meta name="prism.keyword" content=" antibodies">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/09/28">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1776">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11535.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1776">
            <meta name="citation_title" content="Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity">
            <meta name="citation_abstract" content="Autoimmune thyroid disease (AITD) is often observed together with other autoimmune diseases. The coexistence of two or more autoimmune diseases in the same patient is&amp;nbsp;referred&amp;nbsp;to as polyautoimmunity, and AITD is the autoimmune disease most frequently involved. The occurrence of polyautoimmunity has led to the hypothesis that the affected patients suffer from a generalized dysregulation of their immune system. The present review summarizes recent discoveries&amp;nbsp;unravelling&amp;nbsp;the immunological mechanisms involved in autoimmunity, ranging from natural autoimmunity to disease-specific autoimmunity. Furthermore, the clinical grounds for considering AITD in a setting of polyautoimmunity are explored. A better understanding of these&amp;nbsp;may pave the way for designing new treatment modalities targeting the underlying immune dysregulation when AITD appears in the context of polyautoimmunity.">
            <meta name="citation_description" content="Autoimmune thyroid disease (AITD) is often observed together with other autoimmune diseases. The coexistence of two or more autoimmune diseases in the same patient is&amp;nbsp;referred&amp;nbsp;to as polyautoimmunity, and AITD is the autoimmune disease most frequently involved. The occurrence of polyautoimmunity has led to the hypothesis that the affected patients suffer from a generalized dysregulation of their immune system. The present review summarizes recent discoveries&amp;nbsp;unravelling&amp;nbsp;the immunological mechanisms involved in autoimmunity, ranging from natural autoimmunity to disease-specific autoimmunity. Furthermore, the clinical grounds for considering AITD in a setting of polyautoimmunity are explored. A better understanding of these&amp;nbsp;may pave the way for designing new treatment modalities targeting the underlying immune dysregulation when AITD appears in the context of polyautoimmunity.">
            <meta name="citation_keywords" content="Thyroid autoimmunity, polyautoimmunity, immunology, autoimmune disease, Graves' disease, Hashimoto's thyroiditis, AITD, antibodies">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Sofie Bliddal">
            <meta name="citation_author_institution" content="Department of Medical Endocrinology, Section 2132, Copenhagen University Hospital (Rigshospitalet), Blegdamsvej 9, 2100 Copenhagen, Denmark">
            <meta name="citation_author" content="Claus Henrik Nielsen">
            <meta name="citation_author_institution" content="Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, section 7521, Copenhagen University Hospital (Rigshospitalet), Blegdamsvej 9, 2100 Copenhagen, Denmark">
            <meta name="citation_author" content="Ulla Feldt-Rasmussen">
            <meta name="citation_author_institution" content="Department of Medical Endocrinology, Section 2132, Copenhagen University Hospital (Rigshospitalet), Blegdamsvej 9, 2100 Copenhagen, Denmark">
            <meta name="citation_publication_date" content="2017/09/28">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1776">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11535.1">
            <meta name="citation_firstpage" content="1776">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1776/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1776.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12459 /> <input type=hidden id=articleId name=articleId value=11535 /> <input type=hidden id=xmlUrl value="/articles/6-1776/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1776-v1.xml"> <input type=hidden id=article_uuid value=990f859d-ada4-4be7-a689-798b88c62989 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11535.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11535.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1776"
  },
  "headline": "Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of...",
  "datePublished": "2017-09-28T13:50:28",
  "dateModified": "2017-09-28T13:50:28",
  "author": [
    {
      "@type": "Person",
      "name": "Sofie Bliddal"
    },    {
      "@type": "Person",
      "name": "Claus Henrik Nielsen"
    },    {
      "@type": "Person",
      "name": "Ulla Feldt-Rasmussen"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Autoimmune thyroid disease (AITD) is often observed together with other autoimmune diseases. The coexistence of two or more autoimmune diseases in the same patient is referred to as polyautoimmunity, and AITD is the autoimmune disease most frequently involved. The occurrence of polyautoimmunity has led to the hypothesis that the affected patients suffer from a generalized dysregulation of their immune system. The present review summarizes recent discoveries unravelling the immunological mechanisms involved in autoimmunity, ranging from natural autoimmunity to disease-specific autoimmunity. Furthermore, the clinical grounds for considering AITD in a setting of polyautoimmunity are explored. A better understanding of these may pave the way for designing new treatment modalities targeting the underlying immune dysregulation when AITD appears in the context of polyautoimmunity."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1776.html",
            "name": "Recent advances in understanding autoimmune thyroid disease: the tallest..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding autoimmune thyroid disease: the tallest... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12459 data-id=11535 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11535.1" data-recommended="" data-doi="10.12688/f1000research.11535.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1776/v1/pdf?article_uuid=990f859d-ada4-4be7-a689-798b88c62989" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11535-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11535-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11535-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Bliddal S, Nielsen CH and Feldt-Rasmussen U. Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1776 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11535.1" target=_blank>https://doi.org/10.12688/f1000research.11535.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11535-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11535 id=track-article-signin-11535 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11535?target=/articles/6-1776.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12459 /> <input name=articleId type=hidden value=11535 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:sofiebliddal@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sofie Bliddal</span></a><a href="https://orcid.org/0000-0002-2456-1019" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-2456-1019</div><sup>1</sup>,&nbsp;</span><span class="">Claus Henrik Nielsen<sup>2</sup>,&nbsp;</span><span class="">Ulla Feldt-Rasmussen<sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:sofiebliddal@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sofie Bliddal</span></a><a href="http://orcid.org/0000-0002-2456-1019" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-2456-1019</div><sup>1</sup>,&nbsp;</span><span class="">Claus Henrik Nielsen<sup>2</sup>,&nbsp;</span><span class="">Ulla Feldt-Rasmussen<sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 28 Sep 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11535.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medical Endocrinology, Section 2132, Copenhagen University Hospital (Rigshospitalet), Blegdamsvej 9, 2100 Copenhagen, Denmark<br/> <sup>2</sup> Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, section 7521, Copenhagen University Hospital (Rigshospitalet), Blegdamsvej 9, 2100 Copenhagen, Denmark<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23965-26164></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=26302-26165></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Autoimmune thyroid disease (AITD) is often observed together with other autoimmune diseases. The coexistence of two or more autoimmune diseases in the same patient is&nbsp;referred&nbsp;to as polyautoimmunity, and AITD is the autoimmune disease most frequently involved. The occurrence of polyautoimmunity has led to the hypothesis that the affected patients suffer from a generalized dysregulation of their immune system. The present review summarizes recent discoveries&nbsp;unravelling&nbsp;the immunological mechanisms involved in autoimmunity, ranging from natural autoimmunity to disease-specific autoimmunity. Furthermore, the clinical grounds for considering AITD in a setting of polyautoimmunity are explored. A better understanding of these&nbsp;may pave the way for designing new treatment modalities targeting the underlying immune dysregulation when AITD appears in the context of polyautoimmunity. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Thyroid autoimmunity, polyautoimmunity, immunology, autoimmune disease, Graves' disease, Hashimoto's thyroiditis, AITD, antibodies </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Sofie Bliddal (<a href="mailto:sofiebliddal@gmail.com">sofiebliddal@gmail.com</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Sofie Bliddal </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> S. Bliddal is kindly supported by grants from the Copenhagen University Hospital (Rigshospitalet) and Musikforlæggerne Agnes and Knut Mørk’s Foundation. U. Feldt-Rasmussen is supported by a grant from the Novo Nordisk Foundation. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Bliddal S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Bliddal S, Nielsen CH and Feldt-Rasmussen U. Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1776 (<a href="https://doi.org/10.12688/f1000research.11535.1" target=_blank>https://doi.org/10.12688/f1000research.11535.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 28 Sep 2017, <b>6</b>(F1000 Faculty Rev):1776 (<a href="https://doi.org/10.12688/f1000research.11535.1" target=_blank>https://doi.org/10.12688/f1000research.11535.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 28 Sep 2017, <b>6</b>(F1000 Faculty Rev):1776 (<a href="https://doi.org/10.12688/f1000research.11535.1" target=_blank>https://doi.org/10.12688/f1000research.11535.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d23073e188>Introduction</h2><p class="" id=d23073e191>Autoimmune thyroid diseases (AITDs), comprising the two main entities Hashimoto’s thyroiditis (HT) and Graves’ disease (GD), are the most common autoimmune diseases<sup><a href="#ref-1">1</a></sup> and are often observed together with other autoimmune diseases. The occurrence of two or more diseases in the same patient is often referred to as polyautoimmunity<sup><a href="#ref-2">2</a></sup>. This has led to the hypothesis that many patients with autoimmune disease, in general, suffer from an underlying dysfunction of critical mechanisms ensuring self-tolerance. The present review examines recent advances in the understanding of immunological aspects involved in autoimmunity, ranging from physiological to disease-specific autoimmunity, and explores the clinical grounds for considering thyroid autoimmunity in a setting of polyautoimmunity.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d23073e205>Immunological aspects of polyautoimmunity</h2><div class=section><a name=d23073e208 class=n-a></a><h3 class=section-title>Natural polyautoimmunity</h3><p class="" id=d23073e213>At the beginning of the 20th century, Paul Ehrlich demonstrated that animals do not produce antibodies against their own red blood cells and coined the term “horror autotoxicus” for the immune system’s reaction with the body’s own constituents<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. At the same time, the normal occurrence of autoantibodies against spermatozoa was demonstrated<sup><a href="#ref-5">5</a></sup>. Since then, many studies have shown the existence of autoantibodies in healthy animals and humans, referred to as natural autoantibodies<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. In general, natural autoantibodies show broad reactivity against more self- and non-self-antigens and are of the IgM isotype<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a></sup>, whereas disease-associated autoantibodies are of the IgG isotype and bind specific self-antigens with high affinity<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a></sup>. At least in mice, the subset of B cells producing natural autoantibodies appears to be positively selected for self-reactivity in the bone marrow<sup><a href="#ref-11">11</a></sup>. Although B cells and T cells binding to “self” with high affinity are negatively selected, self-reactive lymphocytes with low-affinity receptors are allowed to escape and enter the circulation but often without harmful consequences<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. Thus, natural autoantibodies may serve a role in the clearance of aging cells and cells with tumor potential and may also exert anti-inflammatory control over B cells and T cells<sup><a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>. Natural autoimmunity should therefore should be distinguished from disease-associated autoimmunity.</p></div><div class=section><a name=d23073e268 class=n-a></a><h3 class=section-title>Loss of self-tolerance</h3><p class="" id=d23073e273>Autoimmune disease is preceded by loss of immunological self-tolerance, which may occur at the central level (during the selection processes described above) or in the periphery. The adaptive immune system’s T cells and B cells usually keep the balance between reacting aptly toward foreign antigens and avoiding attack on “self”. Both T cells and B cells contain subsets of regulatory cells with an immunoregulatory cytokine profile on the one hand and effector cells that produce antibodies or secrete pro-inflammatory cytokines on the other (<a href="#f1">Figure 1</a>). Thus, the traditional view of a T helper type 1 (Th1)/Th2 dichotomy has been abandoned since it became clear that CD4<sup>+</sup> effector T cells can differentiate into several subsets of Th cells which stimulate different parts of the immune system: for example, Th1 cells stimulate cellular immunity and the production of opsonizing antibodies, Th2 cells stimulate IgE production, and Th17 cells stimulate neutrophils. Th1 cells and Th17 cells have been shown to play detrimental roles in many autoimmune diseases, including HT and GD<sup><a href="#ref-16">16</a>,<a href="#ref-17">17</a></sup>. Furthermore, Th17 cells have been associated with chronic inflammation and autoimmune diseases such as systemic lupus erythematosus, Sjögren’s syndrome, and systemic sclerosis<sup><a href="#ref-18">18</a></sup>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12459/7c97d400-a25e-4514-9246-57197913a107_figure1.gif"><img alt="7c97d400-a25e-4514-9246-57197913a107_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12459/7c97d400-a25e-4514-9246-57197913a107_figure1.gif"></a><div class=caption><h3>Figure 1. B-cell and T-cell subsets controlling autoimmunity.</h3><p id=d23073e303>Peripheral self-tolerance is ensured by regulatory B cells and T cells. Autoimmunity (loss of self-tolerance) is considered to be due to a shift in favor of pro-inflammatory effector cells. B<sub>eff</sub>, effector B cells; B<sub>reg</sub>, regulatory B cells; DC, dendritic cell; IL, interleukin; iT<sub>reg</sub>, induced regulatory T cells; TGF-β, transforming growth factor beta; Th<sub>1,2,17</sub>, effector CD4<sup>+</sup> T-cell subsets with different cytokine profiles.</p></div></div><p class="" id=d23073e325>Regulatory T cells (Tregs) are primarily responsible for maintaining self-tolerance, and a protective role of Tregs has been demonstrated in several animal models of autoimmune diseases<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. A subset of Tregs known as natural Tregs (nTregs) leave the thymus as fully differentiated cells, whereas another subset, inducible Tregs (iTregs), can be induced from naïve Th0 cells<sup><a href="#ref-21">21</a></sup>. Both subsets are characterized by the expression of the transcription factor forkhead box protein 3 (FOXP3) and mediate their action in part via the secretion of interleukin-10 (IL-10) and transforming growth factor beta (TGF-β)<sup><a href="#ref-22">22</a></sup> and in part by mechanisms involving cell-to-cell contact<sup><a href="#ref-23">23</a></sup>. Loss of peripheral self-tolerance is considered to be the result of an overweight of Th17 cell response as compared with induced regulatory Th10 cell response<sup><a href="#ref-18">18</a></sup>. FOXP3 is involved in the peripheral self-tolerance processes by promoting the development of Tregs while inhibiting the differentiation of Th17 cells<sup><a href="#ref-21">21</a></sup>. Mutations of the <i>Foxp3</i> gene can cause the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, an early-onset, life-threatening autoimmunity characterized by substantial polyautoimmunity and often death within two years of birth<sup><a href="#ref-24">24</a></sup>. Under less severe circumstances, overexpression of FOXP3Δ2, a splice variant of FOXP3 lacking exon 2<sup><a href="#ref-25">25</a></sup>, may be associated with a shift toward a Th17 response, thereby increasing autoantibody production, as shown in a recent study of patients with HT<sup><a href="#ref-26">26</a></sup>. Accordingly, a skewed balance between Th17 cells and Tregs<sup><a href="#ref-18">18</a>,<a href="#ref-21">21</a>,<a href="#ref-26">26</a></sup> as well as dysfunctional Tregs<sup><a href="#ref-19">19</a></sup> have been demonstrated in autoimmune disease in humans. A shift between Th10 and Th17 cells may occur according to the cytokine milieu in the microenvironment<sup><a href="#ref-18">18</a>,<a href="#ref-27">27</a></sup>. Recently, regulatory B cells (Bregs) have received much attention as inhibitors of inflammatory and autoimmune responses by the production of regulatory cytokines (primarily IL-10)<sup><a href="#ref-18">18</a></sup>. Another factor that may contribute to the development of autoimmune disease is therefore a cytokine expression dominated by effector B cells rather than by Bregs. Thus, both Tregs and Bregs contribute to the maintenance of peripheral tolerance (<a href="#f1">Figure 1</a>).</p></div><div class=section><a name=d23073e401 class=n-a></a><h3 class=section-title>Development of autoimmune disease</h3><p class="" id=d23073e406>The transition from natural to clinically manifesting autoimmunity relies on an interplay between genetic predispositions and environmental events, as depicted in Weetman’s “Swiss cheese model” on AITD (<a href="#f2">Figure 2</a>)<sup><a href="#ref-28">28</a></sup>. Most autoimmune diseases are associated with specific variants of the human leukocyte antigen (<i>HLA</i>) genes. Several other genetic polymorphisms have been associated with autoimmune diseases, particularly some located at the genes encoding cytotoxic T lymphocyte-associated 4 (CTLA-4) and the protein tyrosine phosphatase, non-receptor type 22 (PTPN22)<sup><a href="#ref-29">29</a></sup>. Each of these loci encodes molecules involved in the regulation of T cells. In particular, two rare syndromes illustrate the importance of T cells in maintaining self-tolerance: the first, autoimmune polyglandular syndrome type I (APS 1, also called APECED), is caused by defects in the autoimmune regulator (<i>AIRE</i>) gene that mediates the induction of T-cell self-tolerance in the thymus<sup><a href="#ref-30">30</a></sup>. In patients with APS 1, multiple endocrine glands are dysfunctional. The second, FOXP3 deficiency, is associated with the IPEX syndrome, as mentioned above. Whereas APS 1 and IPEX syndrome are caused by mutation of a single gene, most cases of autoimmunity are likely the result of a broad range of genetic predispositions and environmental factors resulting in an imbalance of the peripheral self-tolerance mechanisms sustained by Tregs and Bregs (<a href="#f1">Figure 1</a>)<sup><a href="#ref-18">18</a></sup>. Thus, genetic polymorphisms in self-antigens, cytokines, estrogen receptors, and adhesion molecules have also been linked to the development of autoimmune disease<sup><a href="#ref-28">28</a>,<a href="#ref-31">31</a>–<a href="#ref-36">36</a></sup>, as have genes coding for apoptotic processes<sup><a href="#ref-37">37</a></sup>.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12459/7c97d400-a25e-4514-9246-57197913a107_figure2.gif"><img alt="7c97d400-a25e-4514-9246-57197913a107_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12459/7c97d400-a25e-4514-9246-57197913a107_figure2.gif"></a><div class=caption><h3>Figure 2. Etiology of thyroid autoimmunity.</h3><p id=d23073e462>The development of autoimmune thyroid disease is a result of multiple events—a “Swiss cheese model”. Figure reproduced with kind permission from Weetman<sup><a href="#ref-28">28</a></sup>. HLA, human leukocyte antigen.</p></div></div><p class="" id=d23073e473>In addition to genetic variation, both post-transcriptional and post-translational events may contribute to the development of autoimmunity. Thus, translation of mRNA into protein may be regulated by binding of RNA-binding protein and microRNAs, and alternative splicing of mRNA may influence the functionality of encoded proteins<sup><a href="#ref-28">38</a></sup>. As mentioned above, certain splice variants of FOXP3 mRNA have been associated with autoimmune disease, including HT<sup><a href="#ref-26">26</a>,<a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>. An example of post-translational modification that enhances the immunogenicity of self-proteins is the conversion of arginine residues into citrulline residues, which has a major impact on autoantibody formation in rheumatoid arthritis<sup><a href="#ref-41">41</a></sup>.</p><p class="" id=d23073e494>Several environmental factors may trigger autoimmune disease in genetically predisposed individuals, including bacterial and viral infections, cigarette smoking, maternal-fetal microchimerism<sup><a href="#ref-42">42</a>,<a href="#ref-43">43</a></sup>, and exposure to chemical compounds (flame retardants and phthalates)<sup><a href="#ref-44">44</a></sup>, to mention but a few. Finally, being female predisposes to many autoimmune diseases, which may relate to hormonal factors and to X-chromosome inactivation patterns<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>.</p></div><div class=section><a name=d23073e516 class=n-a></a><h3 class=section-title>Autoimmune thyroid disease</h3><p class="" id=d23073e521>AITD is increasingly viewed as a continuum not only including distinct disease entities—that is, HT, GD, subacute thyroiditis, primary myxedema, and Graves’ orbitopathy (GO)—but covering a spectrum of diseases affecting the thyroid gland. However, in most thyroid research and in clinical practice, the two main entities of AITD remain as GD and HT with typically opposing main clinical manifestations: hyperthyroidism and hypothyroidism, respectively. In line with a more flexible view of AITD, both HT and GD are heterogeneous and can cause both hyperthyroidism and hypothyroidism<sup><a href="#ref-47">47</a></sup>, even alternating between one form and the other<sup><a href="#ref-48">48</a></sup>. GD and HT are among the most common autoimmune diseases in Western countries<sup><a href="#ref-49">49</a></sup>. The pathogenesis is complex with a wide range of predisposing environmental, endogenous, and genetic factors, as described above and specified in relation to AITD in <a href="#B1">Box 1</a><sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a>,<a href="#ref-50">50</a>–<a href="#ref-52">52</a></sup>.</p><p class="" id=d23073e551> <div class="boxed-text panel clearfix"><a name=B1 class=n-a></a><div class=caption><h3>Box 1. Risk factors for autoimmune thyroid disease</h3></div><p class="" id=d23073e564>Environmental</p><div class=list><a name=d23073e567 class=n-a></a><ul style="list-style-type: none"><li><p id=d23073e574><span class=label>▪</span> Iodine consumption</p></li><li><p id=d23073e583><span class=label>▪</span> Smoking (possibly protective)</p></li><li><p id=d23073e592><span class=label>▪</span> Radiation</p></li><li><p id=d23073e601><span class=label>▪</span> Drugs (including biologic agents)</p></li><li><p id=d23073e610><span class=label>▪</span> Alcohol consumption (protective)</p></li><li><p id=d23073e620><span class=label>▪</span> Pollutants</p></li><li><p id=d23073e629><span class=label>▪</span> Selenium? Vitamin D?</p></li><li><p id=d23073e638><span class=label>▪</span> Infections (<i>Yersinia enterocolitica</i>)?</p></li><li><p id=d23073e650><span class=label>▪</span> Improved hygiene?</p></li></ul></div><p class="" id=d23073e655>Endogenous</p><div class=list><a name=d23073e659 class=n-a></a><ul style="list-style-type: none"><li><p id=d23073e666><span class=label>▪</span> Female sex</p></li><li><p id=d23073e675><span class=label>▪</span> Parity</p></li><li><p id=d23073e684><span class=label>▪</span> Aging</p></li><li><p id=d23073e693><span class=label>▪</span> Stress hormones</p></li><li><p id=d23073e702><span class=label>▪</span> Fetal microchimerism</p></li></ul></div><p class="" id=d23073e707>Genetic</p><div class=list><a name=d23073e710 class=n-a></a><ul style="list-style-type: none"><li><p id=d23073e717><span class=label>▪</span> Chromosome abnormalities</p></li><li><p id=d23073e726><span class=label>▪</span> Human leukocyte antigen types?</p></li><li><p id=d23073e735><span class=label>▪</span> Single-nucleotide polymorphisms?</p></li></ul></div></div> </p><p class="" id=d23073e742>HT is characterized by a direct T-cell attack on the thyroid gland, leading to thyroiditis and subsequent exposure of thyroid antigens (thyroid peroxidase and thyroglobulin) against which antibodies are then produced. Thyroglobulin antibodies (TgAbs) and thyroid peroxidase antibodies (TPOAbs) are commonly associated with HT with a destructive pattern and are considered diagnostic for this disease. In any iodine-sufficient population, however, the prevalence of TPOAbs and TgAbs is much higher than that of clinical disease, amounting to approximately 15–25%, with the highest prevalence in females and increasing with age<sup><a href="#ref-53">53</a></sup>. GD is also primarily caused by a T-cell abnormality, but the hyperthyroidism associated with the disease is caused by the production of the pathognomonic thyrotropin receptor autoantibodies (TRAbs). The stimulating effect of TRAbs on thyrocytes probably has an influence on the formation of TgAbs and TPOAbs as well<sup><a href="#ref-54">54</a></sup>. GD (and less commonly HT) can be complicated by GO, an autoimmune reaction in the orbita causing fibroadipose tissue and extraocular muscles to increase in size with a risk of permanent damage to the optic nerve. Shared antigens between the thyroid and orbita have been suspected to be the target of the autoimmune response, and TRAbs are likely to play a part in the pathogenesis. A general inflammatory cytokine profile (mainly Th1-driven) and autoimmune reactions toward the insulin-like growth factor 1 receptor (IGF-1R) have been demonstrated as well<sup><a href="#ref-55">55</a></sup>.</p></div><div class=section><a name=d23073e759 class=n-a></a><h3 class=section-title>Polyautoimmune disease</h3><p class="" id=d23073e764>Occasionally, patients suffer from more than one well-defined autoimmune disease. In the 1950s, it was recognized that certain “shared threads” characterized autoimmune diseases<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup>, a notion which has since been the subject of much debate and research. Many terms have been suggested for such conditions: polyautoimmunity<sup><a href="#ref-2">2</a>,<a href="#ref-58">58</a></sup>, autoimmune diathesis<sup><a href="#ref-57">57</a></sup>, autoimmune tautology<sup><a href="#ref-59">59</a></sup>, or, in the case of three or more coexisting autoimmune diseases, multiple autoimmune syndromes<sup><a href="#ref-60">60</a></sup>. Lack of a common terminology challenges any comprehensive literature search and review. In the following, the term “polyautoimmunity” is used to describe the coexistence of two or more autoimmune diseases in the same patient.</p><p class="" id=d23073e793>Several endocrine syndromes including more than one autoimmune disease have been described (a sample of them is illustrated in <a href="#T1">Table 1</a><sup><a href="#ref-61">61</a>–<a href="#ref-64">64</a></sup>). In polyglandular autoimmune syndrome type 2, Addison’s disease occurs with AITD or type 1 diabetes (as well as with other autoimmune presentations)<sup><a href="#ref-61">61</a></sup>. Such syndromes or classified clusters are rare in contrast to the presence of multiple autoantibodies (independent of clinical diagnoses) in patients with autoimmune disease. AITD, being the most common, is prevalent in most polyautoimmune syndromes and cases. The following sections describe the clinical findings related to thyroid autoimmunity in association with other autoimmunity.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Polyautoimmune endocrine syndromes including thyroid disease.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d23073e820 class=n-a></a><thead><a name=d23073e822 class=n-a></a><tr><a name=d23073e824 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d23073e826 class=n-a></a>Clusters</th><th align=left colspan=1 rowspan=1 valign=top><a name=d23073e829 class=n-a></a>Proposed pathogenic mechanism</th></tr></thead><tbody><a name=d23073e834 class=n-a></a><tr><a name=d23073e836 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d23073e838 class=n-a></a>Autoimmune polyglandular syndromes<sup><a href="#ref-61">61</a></sup></td><td colspan=1 rowspan=1><a name=d23073e844 class=n-a></a></td></tr><tr><a name=d23073e847 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e849 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;Type I (autoimmune polyglandular syndrome type I<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;or Whitaker syndrome): mucosal and cutaneous<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;<i>Candida</i> infections, Addison’s disease, hyposplenism,<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;hypoparathyroidism, and multiple autoimmune<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;presentations (that is, hypothyroidism, hypogonadism,<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;vitiligo, alopecia, pernicious anemia, and chronic<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;autoimmune hepatitis)</td><td colspan=1 rowspan=1 valign=top><a name=d23073e868 class=n-a></a>Mutation of autoimmune regulator (<i>AIRE</i>)<br class=br>gene involved in central tolerance<br class=br>development. Phenotype possibly affected<br class=br>by human leukocyte antigen (HLA)<br class=br>subtypes<sup><a href="#ref-62">62</a></sup>.</td></tr><tr><a name=d23073e888 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e890 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;Type II (Schmidt’s syndrome): Addison’s disease and<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;hypothyroidism or type 1A diabetes as well as pernicious<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;anemia, primary hypogonadism, vitiligo, celiac disease,<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;and myasthenia gravis (by some further classified in<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;types III and IV according to specific entities above)</td><td colspan=1 rowspan=1 valign=top><a name=d23073e901 class=n-a></a>Polygenetic with increased risk of disease<br class=br>linked to specific HLA-DR and HLA-DQ<br class=br>genotypes<sup><a href="#ref-63">63</a></sup></td></tr><tr><a name=d23073e912 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e914 class=n-a></a>Immune dysregulation, polyendocrinopathy, enteropathy,<br class=br>X-linked (IPEX) syndrome<sup><a href="#ref-24">24</a></sup><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Immune dysfunction, enteropathy, dermatitis, autoimmune<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;endocrinopathies (often type 1 diabetes and autoimmune<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;thyroid disease), autoimmune skin diseases (that is,<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;bullous pemphigoid), and multiple organ involvement</td><td colspan=1 rowspan=1 valign=top><a name=d23073e930 class=n-a></a>Mutation of <i>FOXP3</i> gene on the X<br class=br>chromosome</td></tr><tr><a name=d23073e939 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e941 class=n-a></a>Multiple autoimmune syndromes<sup><a href="#ref-60">60</a></sup></td><td colspan=1 rowspan=1><a name=d23073e947 class=n-a></a></td></tr><tr><a name=d23073e951 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d23073e953 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;Type I: myasthenia gravis, thymoma, polymyositis, and<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;giant cell myocarditis</td><td colspan=1 rowspan=1><a name=d23073e958 class=n-a></a></td></tr><tr><a name=d23073e961 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e963 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;Type II: Sjögren’s syndrome, rheumatoid arthritis, primary<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;biliary cirrhosis, scleroderma, and autoimmune thyroid<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;disorders</td><td colspan=1 rowspan=1><a name=d23073e970 class=n-a></a></td></tr><tr><a name=d23073e973 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e975 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;Type III: autoimmune thyroid disease, myasthenia and/or<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;thymoma, Sjögren’s syndrome, pernicious anemia,<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;idiopathic thrombocytopenic purpura, Addison’s disease,<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;insulin-dependent diabetes, vitiligo, autoimmune<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;hemolytic anemia, and systemic lupus erythematosus</td><td colspan=1 rowspan=1 valign=top><a name=d23073e986 class=n-a></a>Genetic predisposition, with phenotype<br class=br>HLA B8 and/or DR3 or DR5 seeming to be<br class=br>an important factor</td></tr><tr><a name=d23073e994 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e996 class=n-a></a>Thyrogastric cluster<sup><a href="#ref-64">64</a></sup><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Autoimmune thyroiditis, chronic gastritis/pernicious<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;anemia, and autoimmune adrenalitis (Addison’s)</td><td colspan=1 rowspan=1 valign=top><a name=d23073e1006 class=n-a></a>Polygenetic</td></tr><tr><a name=d23073e1010 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e1012 class=n-a></a>Lupus-associated cluster<sup><a href="#ref-64">64</a></sup><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Autoimmune hemolytic anemia, immune<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;thrombocytopenia, systemic lupus erythematosus,<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;rheumatoid arthritis, autoimmune hepatitis, and Sjögren’s<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;syndrome</td><td colspan=1 rowspan=1 valign=top><a name=d23073e1026 class=n-a></a>Polygenetic</td></tr><tr><a name=d23073e1030 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e1032 class=n-a></a>Trisomy 21 and Turner syndrome<sup><a href="#ref-64">64</a></sup><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Chronic thyroiditis, type 1A diabetes, and others</td><td colspan=1 rowspan=1 valign=top><a name=d23073e1040 class=n-a></a>Chromosomal abnormalities</td></tr><tr><a name=d23073e1045 class=n-a></a><td colspan=1 rowspan=1><a name=d23073e1047 class=n-a></a>Kearns-Sayre syndrome<sup><a href="#ref-64">64</a></sup><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;External ophthalmoplegia, retinal degeneration, diabetes,<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;thyroiditis, and hypoparathyroidism</td><td colspan=1 rowspan=1 valign=top><a name=d23073e1057 class=n-a></a>Mitochondrial myopathy</td></tr></tbody></table></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d23073e1068>Thyroid autoimmunity in association with polyautoimmunity</h2><div class=section><a name=d23073e1071 class=n-a></a><h3 class=section-title>Thyroid autoimmunity in other autoimmune disease</h3><p class="" id=d23073e1076>It is beyond the scope of this review to cover the numerous case reports describing polyautoimmunity. Instead, the present review will focus on clinical studies on polyautoimmunity involving AITD. In many studies, no distinction has been made between the various clinical phenotypes of AITD, and TgAbs, TPOAbs, and even TRAbs are often just referred to as “thyroid autoantibodies”, making reported percentages indicative only.</p><p class="" id=d23073e1079>In a Colombian study<sup><a href="#ref-2">2</a></sup>, patterns of clustering were investigated among 1,083 patients. The patients had systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, or multiple sclerosis. AITD was the most prevalent disease, coexisting with systemic sclerosis in 23% of cases, rheumatoid arthritis in 21% of cases, systemic lupus erythematosus in 18% of cases, and multiple sclerosis in 9%<sup><a href="#ref-2">2</a></sup>. No control group was provided to substantiate the findings. Among 479 patients with primary Sjögren’s syndrome, Zeher <i>et al</i>. found 21% with AITD<sup><a href="#ref-65">65</a></sup>. Another study from the same group showed that HT was significantly more prevalent than GD in patients with mixed connective tissue disease, rheumatoid arthritis, and Sjögren’s syndrome and that both AITDs were much more prevalent in such patients than in the background population<sup><a href="#ref-66">66</a></sup>. A total of 8.2% of investigated patients with the investigated systemic autoimmune diseases had AITD based on clinical evaluation, imaging, and fine needle aspiration cytology<sup><a href="#ref-66">66</a></sup>.</p><p class="" id=d23073e1106>A few studies of autoantibody prevalence have included healthy controls. Nakamura <i>et al</i>.<sup><a href="#ref-67">67</a></sup> found significant increases in TgAb and TPOAb positivity in all investigated autoimmune diseases compared with healthy controls: up to 50% in type 1 diabetes, 55% in autoimmune liver disease, 26% in myasthenia gravis, and 34% in connective tissue diseases<sup><a href="#ref-67">67</a></sup>. Only patients with type 1 diabetes had TRAbs more often than healthy controls (20% versus 0%, <i>P</i> &lt;0.01). Interestingly, Liao <i>et al</i>.<sup><a href="#ref-68">68</a></sup> found no significant difference in thyroid autoantibody positivity between 1,290 patients with rheumatoid arthritis and 1,236 controls without rheumatic disease (TPOAbs 15.6% versus 15.9%, TgAbs 1.1% versus 0.7%, <i>P</i> &gt;0.05)<sup><a href="#ref-68">68</a></sup>. We have previously found TPOAbs in 5% of patients with rheumatoid arthritis, 19% with type 1 diabetes mellitus, 11% with Sjögren’s syndrome, 56% with pernicious anemia, and 22% with primary biliary cirrhosis compared with 98% with HT and 7% in healthy controls, which is in keeping with the above-mentioned increased risk of autoimmune disease and not only positivity for autoantibody<sup><a href="#ref-69">69</a></sup>.</p></div><div class=section><a name=d23073e1143 class=n-a></a><h3 class=section-title>Non-thyroid autoantibodies and other autoimmune disease in autoimmune thyroid disease</h3><p class="" id=d23073e1148>Few studies have investigated the prevalence of non-thyroid autoantibodies or other autoimmune diseases in patients with AITD. In a recently published prospective study, 3,069 patients with chronic AITD were compared with 1,023 patients with non-toxic nodular goiter and 1,023 healthy controls<sup><a href="#ref-70">70</a></sup>. Diagnosis of autoimmune disease was confirmed by a specialist according to scientific societies’ criteria. Several of the concurrent autoimmune diseases were significantly more prevalent in patients with AITD than in the healthy controls. However, only three concurrent diseases had a prevalence of more than 2% in the AITD group: chronic autoimmune gastritis, vitiligo, and rheumatoid arthritis. Among observed clusters of disease, AITD together with chronic autoimmune gastritis and vitiligo formed a cluster with a significantly increased prevalence in the group of patients with AITD (12 patients versus 0 in other groups, <i>P</i> = 0.02)<sup><a href="#ref-70">70</a></sup>.</p><p class="" id=d23073e1162>In a Japanese population of patients with AITD, anti-glutamic acid decarboxylase antibodies were the most prevalent non-thyroid autoantibodies, being present in 6.4% of GD and in 4.6% of patients with HT<sup><a href="#ref-67">67</a></sup>, thus confirming historical links between insulin antibodies and thyroid autoimmunity<sup><a href="#ref-71">71</a></sup>. In a study of more than 3,000 UK patients with AITD, there was a significantly increased relative risk of any other autoimmune disease screened for compared with the background population<sup><a href="#ref-72">72</a></sup>. Thus, 14.3% of the 495 patients with HT and 9.7% with GD had at least one other autoimmune disease, mainly type 1 diabetes, rheumatoid arthritis, and pernicious anemia. Wiebolt <i>et al</i>. investigated 359 patients with HT and 523 with GD and found differing patterns of autoantibody clustering in the two diseases<sup><a href="#ref-73">73</a></sup>. Thus, adrenal autoimmunity combined with beta-cell or gastric autoimmunity was more common in patients with HT compared with patients with GD<sup><a href="#ref-73">73</a></sup>.</p></div><div class=section><a name=d23073e1190 class=n-a></a><h3 class=section-title>Epidemiological studies</h3><p class="" id=d23073e1195>Lack of power in clinical studies is made up for in epidemiologic studies. Eaton <i>et al</i>. included data from more than 5 million Danes from hospital registries to investigate the prevalence of 31 specified autoimmune diseases (based on the International Classification of Diseases 10th Revision (ICD10) classification system)<sup><a href="#ref-74">74</a>,<a href="#ref-75">75</a></sup>. Although data were limited to that of specialized care, the estimated lifetime prevalence of any autoimmune disease was 5.3%, and AITD most often coexisted with adrenal disease (odds ratio (OR) 12.9), alopecia areata (OR 11.4), vitiligo (OR 7.9), and pernicious anemia (OR 5.6)<sup><a href="#ref-75">75</a></sup>. However, compared with connective tissue diseases in particular, AITD showed limited overlap with other autoimmune diseases. As many patients with autoimmune disease are handled in general practice, a British study used the United Kingdom General Practice Research Database to study the intra-individual risk of polyautoimmunity<sup><a href="#ref-76">76</a></sup>. Along with large numbers of patients with insulin-dependent diabetes mellitus, rheumatoid arthritis, and multiple sclerosis, 26,198 patients with AITD were included. Patients with either AITD or rheumatoid arthritis were at risk of developing the other disease (sex-specific standardized incidence rate of 130.4–162.0)<sup><a href="#ref-76">76</a></sup>. The risk of patients with type 1 diabetes having AITD was increased significantly in comparison with the background population having AITD; with a prevalence six times higher in males and a prevalence four times higher in females. This is in keeping with at least one previous cohort study, where patients with two autoimmune diseases, and thus probably stronger influence of genetic than environmental or other inherent factors, seemed to show a diminished or even abolished female preponderance of autoimmune diseases that is otherwise observed in the general population<sup><a href="#ref-77">77</a></sup>. Thus, the <i>a priori</i> likelihood of contracting a second autoimmune disease is higher in males than in females with one autoimmune disease, which should be taken into account when managing male patients with AITD. Despite many inherent limitations, epidemiological studies provide further evidence of an increased risk of polyautoimmunity in patients with AITD. Without proving causality, the association between AITD and other autoimmune diseases seems well substantiated and with no strict distinction between organ-specific and non-organ-specific autoimmune disease.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d23073e1232>Clinical consequences of polyautoimmunity in thyroid autoimmunity</h2><div class=section><a name=d23073e1235 class=n-a></a><h3 class=section-title>Clinical impact of (poly)autoimmunity</h3><p class="" id=d23073e1240>The chronic nature of autoimmune disease implies high socioeconomic costs as well as a profound impact on the patient’s health and well-being<sup><a href="#ref-78">78</a></sup>. The occurrence of polyautoimmunity rather than an isolated autoimmune disease may greatly affect prognosis. In a Dutch study, TPOAb positivity in patients with rheumatoid arthritis was predictive of disease activity—measured by the Disease Activity Score using 28 joint counts (DAS28)—and of increased carotid intima-media thickness at a 2-year follow-up<sup><a href="#ref-79">79</a></sup>. The latter finding may indicate an increased risk of cardiovascular disease in patients with polyautoimmunity in accordance with the well-established association between increased inflammation and risk of cardiovascular disease<sup><a href="#ref-80">80</a>,<a href="#ref-81">81</a></sup>. In studies of reproductive failure, especially autoantibodies involved in the anti-phospholipid syndrome (that is, anti-cardiolipin antibodies)<sup><a href="#ref-82">82</a></sup> but also thyroid autoantibodies<sup><a href="#ref-83">83</a>,<a href="#ref-84">84</a></sup> have been associated with worsened pregnancy outcomes. In a study by Iijima <i>et al</i>.<sup><a href="#ref-85">85</a></sup>, several autoantibodies were analyzed, and women with autoantibodies against one or more self-antigens had a significantly increased risk of miscarriage. However, only 5% of all women (25.8% of autoantibody-positive women) had multiple autoantibodies<sup><a href="#ref-85">85</a></sup>. In women with recurrent pregnancy loss, a thorough examination of possible polyautoimmune etiology is therefore warranted, and immunotherapy appears to be beneficial<sup><a href="#ref-86">86</a></sup>.</p><p class="" id=d23073e1285>Few studies indicate an impact of an underlying immunological tolerance breach rather than thyroid dysfunction on the symptomatology involved in AITD. Abnormal brain perfusion in patients with euthyroid HT compared with controls has led to a hypothesis of an autoimmune component in decreased vascularization, possibly causing psychiatric symptoms in patients with AITD<sup><a href="#ref-87">87</a>,<a href="#ref-88">88</a></sup>. Also, a study of patient-reported outcomes (PROs) in Danish patients with AITD found a significant continuous reduction of outcomes, including physical functioning despite euthyroidism<sup><a href="#ref-89">89</a></sup>. A subsequent study found reduced PROs in patients with GD compared with patients with toxic nodular goiter but failed to show an association with thyroid antibody levels<sup><a href="#ref-90">90</a></sup>. Conversely, in studies of patients with systemic sclerosis and myasthenia gravis, those with coexistent AITD were less affected by their disease than patients without thyroid autoimmunity<sup><a href="#ref-91">91</a>,<a href="#ref-92">92</a></sup>. Thus, quantitative increments of autoimmune diagnoses are not always associated with a worsened prognosis.</p><p class="" id=d23073e1310>The possible negative attribution of underlying autoimmunity (for example, GD) rather than thyroid function impairment (for example, multinodular goiter) needs further investigation. The presence of a more general but undiagnosed polyautoimmunity could explain the poorer outcomes of treatment. This has in recent years been acknowledged by endocrinologists and is now introduced in clinical guidelines (for example, for the treatment of hypothyroidism)<sup><a href="#ref-93">93</a></sup>. Before combination therapy with thyroxine and triiodothyronine is considered, a search for other autoimmune diseases in a patient with AITD and poor PROs is now mandatory<sup><a href="#ref-93">93</a></sup>. Thus, it has become relevant to both the clinician and the patient with AITD to be aware of the possibility of polyautoimmunity, not only as an explanatory model of prolonged symptoms but also with respect to a possible altered prognosis of disease and treatment outcome.</p></div><div class=section><a name=d23073e1322 class=n-a></a><h3 class=section-title>The role of immunomodulatory biologic drugs</h3><p class="" id=d23073e1327>The prevalence of thyroid and other autoimmunity will likely be affected by the increasing administration of biologic agents in cancer treatment and internal medicine, developed to target specific parts of the immune system. In multiple sclerosis patients treated with the T cell–depleting anti-CD52 monoclonal antibody alemtuzumab, one third of patients developed GD between 6 and 31 weeks after treatment<sup><a href="#ref-94">94</a></sup>. This was likely due to loss of T cell–mediated immunoregulation. Also, in patients with chronic hepatitis treated with interferon-alpha, up to 40% developed thyroid autoantibodies and 15% developed clinical AITD<sup><a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup>. Stefan <i>et al</i>. found a direct impact of interferon-alpha on the activity of a thyroglobulin promotor region with a specific single-nucleotide polymorphism involved in AITD<sup><a href="#ref-97">97</a></sup>. Finally, biologic drugs stimulating the patient’s own immune response against cancer cells have proven efficient in fighting cancers but may induce various autoimmune diseases. Among such drugs are the checkpoint inhibitors ipilimumab (a monoclonal antibody targeting the CTLA-4 receptor) and nivolumab and pembrolizumab (blocking “programmed cell death 1” proteins on T cells, thus promoting anti-tumor activity). Autoimmune hypophysitis is seen in 4% of patients treated with ipilimumab and in 1% of patients treated with nivolumab or pembrolizumab. Combined treatment with ipilimumab and nivolumab increases the hypophysitis rate to 8%<sup><a href="#ref-98">98</a></sup>. In these patients with autoimmune hypophysitis, secondary adrenal insufficiency develops in up to 100%, hypogonadotropic hypogonadism in up to 85%, and central hypothyroidism in up to 100%<sup><a href="#ref-98">98</a></sup>. More rarely, autoimmune primary thyroid affection or adrenal insufficiency occurs<sup><a href="#ref-99">99</a></sup>. Thus, the use of such drugs should entail a standardized monitoring program to check for endocrinopathies (i.e. life-threatening adrenal insufficiency) and thorough patient information including which symptoms to react upon.</p><p class="" id=d23073e1361>On the other hand, biologic agents may offer new options for treating (poly)autoimmune diseases, including otherwise treatment-resistant AITD. Treatment of rheumatic arthritis patients with biologic agents seems to be safe and to possibly have a positive effect on concurrent AITD<sup><a href="#ref-100">100</a></sup>. In a small study, the treatment of 138 patients with rheumatoid arthritis with the tumor necrosis factor-alpha inhibitor adalimumab led to concurrent improvement of hypothyroidism as well as a reduction in TPOAb levels<sup><a href="#ref-101">101</a></sup>. Incorporation of rituximab, a B cell–depleting agent, has shown promising results in patients with GO<sup><a href="#ref-102">102</a>–<a href="#ref-104">104</a></sup> in addition to ameliorating numerous other autoimmune diseases, such as rheumatoid arthritis<sup><a href="#ref-103">103</a>,<a href="#ref-105">105</a></sup>, multiple sclerosis<sup><a href="#ref-106">106</a></sup>, and type 1 diabetes<sup><a href="#ref-107">107</a></sup>. In a recent study, inhibition of the IGF-1R by use of teprotumumab, an antibody targeting the IGF-1R, also significantly improved outcome in 88 patients with GO<sup><a href="#ref-108">108</a></sup>. The field of drugs targeting immune-mediated diseases is quickly evolving, and numerous drugs have been developed and are undergoing clinical trials<sup><a href="#ref-109">109</a></sup>. Although the mechanisms triggering loss of self-tolerance are still unclear, the increasing knowledge about B-cell and T-cell subsets and different cytokine milieus provides interesting perspectives for refined treatment options in (poly)autoimmune diseases including treatment-resistant AITD. For a summary of learning points, see <a href="#B2">Box 2</a>.</p><p class="" id=d23073e1406> <div class="boxed-text panel clearfix"><a name=B2 class=n-a></a><div class=caption><h3>Box 2. Learning points</h3></div><div class=list><a name=d23073e1419 class=n-a></a><ul><li><p id=d23073e1423>Polyautoimmunity in patients with autoimmune thyroid disease is common but not part of routine screening.</p></li><li><p id=d23073e1429>Polyautoimmunity may increase morbidity due to inflammation.</p></li><li><p id=d23073e1435>Patients with continuous complaints despite euthyroidism may benefit from wider immunological assessment.</p></li><li><p id=d23073e1441>Interdisciplinary assessment is beneficial for polyautoimmune patients.</p></li><li><p id=d23073e1447>Immunomodulatory biologic drugs may be a future treatment option in thyroid autoimmune patients with multiple associated autoantibodies.</p></li></ul></div></div> </p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d23073e1458>Conclusions</h2><p class="" id=d23073e1461>As illustrated above, AITD is often represented in patients with polyautoimmunity, and patients with AITD have an increased risk of developing other autoimmune diseases. In AITD patients with remaining complaints despite euthyroidism or patients presenting with new symptoms, polyautoimmunity should come to mind. Furthermore, the concept of polyautoimmunity may call for a rethinking of treatment strategies in patients with AITD. Current treatment of AITD has focused on securing thyroid hormone homeostasis, but in cases with polyautoimmunity more attention should be drawn to the identification and treatment of the underlying immune dysregulation and inflammation. In years to come, immunomodulatory biologic drugs may serve this purpose.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d23073e1 class=n-a></a><h2 class=main-title id=d23408>Author contributions</h2><p class=metadata-entry><a name=d23073e111 class=n-a></a><p id=d23073e113> SB was in charge of the manuscript preparation. All authors contributed to the conception, discussion, critical review, and approval of the manuscript in accordance with the requirements of the International Committee of Medical Journal Editors. All authors were involved in the revision of the draft manuscript and have agreed to the final content.</p></p></div><div class=back-section><a name=d23073e1 class=n-a></a><h2 class=main-title id=d23412>Competing interests</h2><p class=metadata-entry><a name=d23073e117 class=n-a></a><p id=d23073e119> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d23073e1 class=n-a></a><h2 class=main-title id=d23414>Grant information</h2><p>SB is kindly supported by grants from the Copenhagen University Hospital (Rigshospitalet) and the Musikforlæggerne Agnes and Knut Mørk Foundation. UF-R is supported by a grant from the Novo Nordisk Foundation.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</i>.</p></div><div class=back-section><a name=d23073e1468 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d23757>References</h2><div class="section ref-list"><a name=d23073e1468 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d23073e1475 class=n-a></a>Weetman A, DeGroot LJ: Autoimmunity to the Thyroid Gland. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, <i>et al.</i>, editors. Endotext. South Dartmouth (MA); 2000. <a target=xrefwindow id=d23073e1480 href="http://www.ncbi.nlm.nih.gov/pubmed/25905407">PubMed Abstract </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d23073e1489 class=n-a></a>Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, <i> et al.</i>: Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. <i>Autoimmune Dis.</i> 2012; <b>2012</b>: 254319. <a target=xrefwindow id=d23073e1500 href="http://www.ncbi.nlm.nih.gov/pubmed/22454759">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1503 href="http://dx.doi.org/10.1155/2012/254319">Publisher Full Text </a> | <a target=xrefwindow id=d23073e1507 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3290803">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d23073e1516 class=n-a></a>Ehrlich P: Verh Ges Dtsch Naturforsch. 1902; <b>1</b>: 250–275. </span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d23073e1528 class=n-a></a>Welch WH: The Huxley Lecture on Recent Studies of Immunity, with Special Reference to their Bearing on Pathology: Delivered at the Opening of the Winter Session of Charing Cross Hospital Medical School on October 1st, 1902. <i>Br Med J.</i> 1902; <b>2</b>(2180): 1105–14. <a target=xrefwindow id=d23073e1536 href="http://www.ncbi.nlm.nih.gov/pubmed/20760475">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1539 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2401880">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d23073e1548 class=n-a></a>Metalnikoff S: Ann Inst Pasteur. 1900; <b>14</b>: 577–589. </span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d23073e1561 class=n-a></a>Avrameas S, Selmi C: Natural autoantibodies in the physiology and pathophysiology of the immune system. <i>J Autoimmun.</i> 2013; <b>41</b>: 46–9. <a target=xrefwindow id=d23073e1569 href="http://www.ncbi.nlm.nih.gov/pubmed/23384670">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1572 href="http://dx.doi.org/10.1016/j.jaut.2013.01.006">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d23073e1581 class=n-a></a>Nakamura M, Burastero SE, Ueki Y, <i> et al.</i>: Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto’s disease and systemic lupus erythematosus. <i>J Immunol.</i> 1988; <b>141</b>(12): 4165–72. <a target=xrefwindow id=d23073e1592 href="http://www.ncbi.nlm.nih.gov/pubmed/2848890">PubMed Abstract </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d23073e1601 class=n-a></a>Berneman A, Guilbert B, Eschrich S, <i> et al.</i>: IgG auto- and polyreactivities of normal human sera. <i>Mol Immunol.</i> 1993; <b>30</b>(16): 1499–510. <a target=xrefwindow id=d23073e1612 href="http://www.ncbi.nlm.nih.gov/pubmed/8232336">PubMed Abstract </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d23073e1621 class=n-a></a>Nielsen CH, Bendtzen K: Immunoregulation by naturally occurring and disease-associated autoantibodies: binding to cytokines and their role in regulation of T-cell responses. <i>Adv Exp Med Biol.</i> 2012; <b>750</b>: 116–32. <a target=xrefwindow id=d23073e1629 href="http://www.ncbi.nlm.nih.gov/pubmed/22903670">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1632 href="http://dx.doi.org/10.1007/978-1-4614-3461-0_9">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d23073e1641 class=n-a></a>Nielsen CH, Brix TH, Gardas A, <i> et al.</i>: Epitope recognition patterns of thyroid peroxidase autoantibodies in healthy individuals and patients with Hashimoto’s thyroiditis*. <i>Clin Endocrinol (Oxf).</i> 2008; <b>69</b>(4): 664–8. <a target=xrefwindow id=d23073e1652 href="http://www.ncbi.nlm.nih.gov/pubmed/18363888">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1655 href="http://dx.doi.org/10.1111/j.1365-2265.2008.03245.x">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d23073e1664 class=n-a></a>Hayakawa K, Asano M, Shinton SA, <i> et al.</i>: Positive selection of natural autoreactive B cells. <i>Science.</i> 1999; <b>285</b>(5424): 113–6. <a target=xrefwindow id=d23073e1675 href="http://www.ncbi.nlm.nih.gov/pubmed/10390361">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1678 href="http://dx.doi.org/10.1126/science.285.5424.113">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d23073e1688 class=n-a></a>Nossal GJ: Negative selection of lymphocytes. <i>Cell.</i> 1994; <b>76</b>(2): 229–39. <a target=xrefwindow id=d23073e1696 href="http://www.ncbi.nlm.nih.gov/pubmed/8293461">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1699 href="http://dx.doi.org/10.1016/0092-8674(94)90331-X">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d23073e1708 class=n-a></a>Webb S, Morris C, Sprent J: Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. <i>Cell.</i> 1990; <b>63</b>(6): 1249–56. <a target=xrefwindow id=d23073e1716 href="http://www.ncbi.nlm.nih.gov/pubmed/2148123">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1719 href="http://dx.doi.org/10.1016/0092-8674(90)90420-J">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d23073e1728 class=n-a></a>Lutz HU, Binder CJ, Kaveri S: Naturally occurring auto-antibodies in homeostasis and disease. <i>Trends Immunol.</i> 2009; <b>30</b>(1): 43–51. <a target=xrefwindow id=d23073e1736 href="http://www.ncbi.nlm.nih.gov/pubmed/19058756">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1739 href="http://dx.doi.org/10.1016/j.it.2008.10.002">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d23073e1748 class=n-a></a>Hurez V, Dietrich G, Kaveri SV, <i> et al.</i>: Polyreactivity is a property of natural and disease-associated human autoantibodies. <i>Scand J Immunol.</i> 1993; <b>38</b>(2): 190–6. <a target=xrefwindow id=d23073e1759 href="http://www.ncbi.nlm.nih.gov/pubmed/8346418">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1762 href="http://dx.doi.org/10.1111/j.1365-3083.1993.tb01712.x">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d23073e1771 class=n-a></a>Rapoport B, McLachlan SM: Graves’ hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. <i>J Clin Endocrinol Metab.</i> 2014; <b>99</b>(11): 4060–1. <a target=xrefwindow id=d23073e1779 href="http://www.ncbi.nlm.nih.gov/pubmed/25210884">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1782 href="http://dx.doi.org/10.1210/jc.2014-3011">Publisher Full Text </a> | <a target=xrefwindow id=d23073e1785 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4223433">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d23073e1794 class=n-a></a>Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, <i> et al.</i>: Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis. <i>J Clin Endocrinol Metab.</i> 2010; <b>95</b>(2): 953–62. <a target=xrefwindow id=d23073e1805 href="http://www.ncbi.nlm.nih.gov/pubmed/20016049">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1808 href="http://dx.doi.org/10.1210/jc.2009-1719">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727398096"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e1818 class=n-a></a>Papp G, Boros P, Nakken B, <i> et al.</i>: Regulatory immune cells and functions in autoimmunity and transplantation immunology. <i>Autoimmun Rev.</i> 2017; <b>16</b>(5): 435–44. <a target=xrefwindow id=d23073e1829 href="http://www.ncbi.nlm.nih.gov/pubmed/28286106">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1832 href="http://dx.doi.org/10.1016/j.autrev.2017.03.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727398096">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d23073e1845 class=n-a></a>Ramos-Leví AM, Marazuela M: Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. <i>Endocrinol Nutr.</i> 2016; <b>63</b>(8): 421–9. <a target=xrefwindow id=d23073e1853 href="http://www.ncbi.nlm.nih.gov/pubmed/27234136">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1856 href="http://dx.doi.org/10.1016/j.endonu.2016.04.003">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d23073e1865 class=n-a></a>Morris GP, Brown NK, Kong YM: Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. <i>J Autoimmun.</i> 2009; <b>33</b>(1): 68–76. <a target=xrefwindow id=d23073e1873 href="http://www.ncbi.nlm.nih.gov/pubmed/19375891">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1876 href="http://dx.doi.org/10.1016/j.jaut.2009.03.010">Publisher Full Text </a> | <a target=xrefwindow id=d23073e1879 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2706097">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725855764"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e1888 class=n-a></a>González-Amaro R, Marazuela M: T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. <i>Endocrine.</i> 2016; <b>52</b>(1): 30–8. <a target=xrefwindow id=d23073e1896 href="http://www.ncbi.nlm.nih.gov/pubmed/26475497">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1899 href="http://dx.doi.org/10.1007/s12020-015-0759-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725855764">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d23073e1912 class=n-a></a>Roncarolo MG, Gregori S, Battaglia M, <i> et al.</i>: Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. <i>Immunol Rev.</i> 2006; <b>212</b>: 28–50. <a target=xrefwindow id=d23073e1923 href="http://www.ncbi.nlm.nih.gov/pubmed/16903904">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1926 href="http://dx.doi.org/10.1111/j.0105-2896.2006.00420.x">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d23073e1935 class=n-a></a>von Boehmer H: Mechanisms of suppression by suppressor T cells. <i>Nat Immunol.</i> 2005; <b>6</b>(4): 338–44. <a target=xrefwindow id=d23073e1943 href="http://www.ncbi.nlm.nih.gov/pubmed/15785759">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1946 href="http://dx.doi.org/10.1038/ni1180">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d23073e1956 class=n-a></a>Bennett CL, Christie J, Ramsdell F, <i> et al.</i>: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of <i>FOXP3</i>. <i>Nat Genet.</i> 2001; <b>27</b>(1): 20–1. <a target=xrefwindow id=d23073e1970 href="http://www.ncbi.nlm.nih.gov/pubmed/11137993">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1974 href="http://dx.doi.org/10.1038/83713">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d23073e1983 class=n-a></a>Allan SE, Passerini L, Bacchetta R, <i> et al.</i>: The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. <i>J Clin Invest.</i> 2005; <b>115</b>(11): 3276–84. <a target=xrefwindow id=d23073e1994 href="http://www.ncbi.nlm.nih.gov/pubmed/16211090">PubMed Abstract </a> | <a target=xrefwindow id=d23073e1997 href="http://dx.doi.org/10.1172/JCI24685">Publisher Full Text </a> | <a target=xrefwindow id=d23073e2001 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1242190">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d23073e2010 class=n-a></a>Kristensen B, Hegedüs L, Madsen HO, <i> et al.</i>: Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto’s thyroiditis. <i>Clin Exp Immunol.</i> 2015; <b>180</b>(1): 58–69. <a target=xrefwindow id=d23073e2021 href="http://www.ncbi.nlm.nih.gov/pubmed/25412700">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2024 href="http://dx.doi.org/10.1111/cei.12557">Publisher Full Text </a> | <a target=xrefwindow id=d23073e2028 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4367094">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d23073e2037 class=n-a></a>Yanaba K, Bouaziz J, Haas KM, <i> et al.</i>: A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. <i>Immunity.</i> 2008; <b>28</b>(5): 639–50. <a target=xrefwindow id=d23073e2048 href="http://www.ncbi.nlm.nih.gov/pubmed/18482568">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2051 href="http://dx.doi.org/10.1016/j.immuni.2008.03.017">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731249392"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2060 class=n-a></a>Weetman AP: The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. <i>Eur Thyroid J.</i> 2013; <b>1</b>(4): 243–50. <a target=xrefwindow id=d23073e2068 href="http://www.ncbi.nlm.nih.gov/pubmed/24783026">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2071 href="http://dx.doi.org/10.1159/000343834">Publisher Full Text </a> | <a target=xrefwindow id=d23073e2074 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3821488">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731249392">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d23073e2087 class=n-a></a>Brand O, Gough S, Heward J: <i>HLA, CTLA-4 and PTPN22</i>: The shared genetic master-key to autoimmunity? <i>Expert Rev Mol Med.</i> 2005; <b>7</b>(23): 1–15. <a target=xrefwindow id=d23073e2098 href="http://www.ncbi.nlm.nih.gov/pubmed/16229750">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2101 href="http://dx.doi.org/10.1017/S1462399405009981">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d23073e2111 class=n-a></a>Mathis D, Benoist C: Aire. <i>Annu Rev Immunol.</i> 2009; <b>27</b>: 287–312. <a target=xrefwindow id=d23073e2119 href="http://www.ncbi.nlm.nih.gov/pubmed/19302042">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2122 href="http://dx.doi.org/10.1146/annurev.immunol.25.022106.141532">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d23073e2131 class=n-a></a>Caputo M, Rivolta CM, Mories T, <i> et al.</i>: Analysis of thyroglobulin gene polymorphisms in patients with autoimmune thyroiditis. <i>Endocrine.</i> 2010; <b>37</b>(3): 389–95. <a target=xrefwindow id=d23073e2142 href="http://www.ncbi.nlm.nih.gov/pubmed/20960158">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2145 href="http://dx.doi.org/10.1007/s12020-010-9317-5">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718685942"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2154 class=n-a></a>Zenewicz LA, Abraham C, Flavell RA, <i> et al.</i>: Unraveling the genetics of autoimmunity. <i>Cell.</i> 2010; <b>140</b>(6): 791–7. <a target=xrefwindow id=d23073e2165 href="http://www.ncbi.nlm.nih.gov/pubmed/20303870">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2168 href="http://dx.doi.org/10.1016/j.cell.2010.03.003">Publisher Full Text </a> | <a target=xrefwindow id=d23073e2172 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3491807">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718685942">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d23073e2185 class=n-a></a>Johar AS, Mastronardi C, Rojas-Villarraga A, <i> et al.</i>: Novel and rare functional genomic variants in multiple autoimmune syndrome and Sjögren’s syndrome. <i>J Transl Med.</i> 2015; <b>13</b>: 173. <a target=xrefwindow id=d23073e2196 href="http://www.ncbi.nlm.nih.gov/pubmed/26031516">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2199 href="http://dx.doi.org/10.1186/s12967-015-0525-x">Publisher Full Text </a> | <a target=xrefwindow id=d23073e2203 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4450850">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d23073e2212 class=n-a></a>Johar AS, Anaya JM, Andrews D, <i> et al.</i>: Candidate gene discovery in autoimmunity by using extreme phenotypes, next generation sequencing and whole exome capture. <i>Autoimmun Rev.</i> 2015; <b>14</b>(3): 204–9. <a target=xrefwindow id=d23073e2223 href="http://www.ncbi.nlm.nih.gov/pubmed/25447288">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2226 href="http://dx.doi.org/10.1016/j.autrev.2014.10.021">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d23073e2235 class=n-a></a>Chu X, Pan CM, Zhao SX, <i> et al.</i>: A genome-wide association study identifies two new risk loci for Graves’ disease. <i>Nat Genet.</i> 2011; <b>43</b>(9): 897–901. <a target=xrefwindow id=d23073e2246 href="http://www.ncbi.nlm.nih.gov/pubmed/21841780">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2249 href="http://dx.doi.org/10.1038/ng.898">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d23073e2259 class=n-a></a>Lee HS, Kang J, Yang S, <i> et al.</i>: Susceptibility influence of a <i>PTPN22</i> haplotype with thyroid autoimmunity in Koreans. <i>Diabetes Metab Res Rev.</i> 2011; <b>27</b>(8): 878–82. <a target=xrefwindow id=d23073e2273 href="http://www.ncbi.nlm.nih.gov/pubmed/22069277">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2277 href="http://dx.doi.org/10.1002/dmrr.1265">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726374560"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2286 class=n-a></a>Johar A, Sarmiento-Monroy JC, Rojas-Villarraga A, <i> et al.</i>: Definition of mutations in polyautoimmunity. <i>J Autoimmun.</i> 2016; <b>72</b>: 65–72. <a target=xrefwindow id=d23073e2297 href="http://www.ncbi.nlm.nih.gov/pubmed/27209085">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2300 href="http://dx.doi.org/10.1016/j.jaut.2016.05.003">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726374560">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727108657"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2313 class=n-a></a>Chen JQ, Papp G, Szodoray P, <i> et al.</i>: The role of microRNAs in the pathogenesis of autoimmune diseases. <i>Autoimmun Rev.</i> 2016; <b>15</b>(12): 1171–80. <a target=xrefwindow id=d23073e2324 href="http://www.ncbi.nlm.nih.gov/pubmed/27639156">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2327 href="http://dx.doi.org/10.1016/j.autrev.2016.09.003">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727108657">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d23073e2340 class=n-a></a>Link M, Salur L, Kisand K, <i> et al.</i>: Higher FoxP3 mRNA expression in peripheral blood mononuclear cells of GAD65 or IA-2 autoantibody-positive compared with autoantibody-negative persons. <i>APMIS.</i> 2008; <b>116</b>(10): 896–902. <a target=xrefwindow id=d23073e2351 href="http://www.ncbi.nlm.nih.gov/pubmed/19132983">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2354 href="http://dx.doi.org/10.1111/j.1600-0463.2008.00889.x">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d23073e2363 class=n-a></a>Ryder LR, Bartels EM, Woetmann A, <i> et al.</i>: FoxP3 mRNA splice forms in synovial CD4+ T cells in rheumatoid arthritis and psoriatic arthritis. <i>APMIS.</i> 2012; <b>120</b>(5): 387–96. <a target=xrefwindow id=d23073e2374 href="http://www.ncbi.nlm.nih.gov/pubmed/22515293">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2377 href="http://dx.doi.org/10.1111/j.1600-0463.2011.02848.x">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727108681"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2386 class=n-a></a>Catrina AI, Svensson CI, Malmström V, <i> et al.</i>: Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. <i>Nat Rev Rheumatol.</i> 2017; <b>13</b>(2): 79–86. <a target=xrefwindow id=d23073e2397 href="http://www.ncbi.nlm.nih.gov/pubmed/27974851">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2400 href="http://dx.doi.org/10.1038/nrrheum.2016.200">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727108681">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d23073e2414 class=n-a></a>Lepez T, Vandewoestyne M, Deforce D: Fetal microchimeric cells in autoimmune thyroid diseases: harmful, beneficial or innocent for the thyroid gland? <i>Chimerism.</i> 2013; <b>4</b>(4): 111–8. <a target=xrefwindow id=d23073e2422 href="http://www.ncbi.nlm.nih.gov/pubmed/23723083">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2425 href="http://dx.doi.org/10.4161/chim.25055">Publisher Full Text </a> | <a target=xrefwindow id=d23073e2428 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3921191">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728897143"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2437 class=n-a></a>Stevens AM: Maternal microchimerism in health and disease. <i>Best Pract Res Clin Obstet Gynaecol.</i> 2016; <b>31</b>: 121–30. <a target=xrefwindow id=d23073e2445 href="http://www.ncbi.nlm.nih.gov/pubmed/26612343">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2448 href="http://dx.doi.org/10.1016/j.bpobgyn.2015.08.005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728897143">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d23073e2461 class=n-a></a>Mynster Kronborg T, Frohnert Hansen J, Nielsen CH, <i> et al.</i>: Effects of the Commercial Flame Retardant Mixture DE-71 on Cytokine Production by Human Immune Cells. <i>PLoS One.</i> 2016; <b>11</b>(4): e0154621. <a target=xrefwindow id=d23073e2472 href="http://www.ncbi.nlm.nih.gov/pubmed/27128973">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2475 href="http://dx.doi.org/10.1371/journal.pone.0154621">Publisher Full Text </a> | <a target=xrefwindow id=d23073e2479 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4851365">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d23073e2488 class=n-a></a>Gleicher N, Barad DH: Gender as risk factor for autoimmune diseases. <i>J Autoimmun.</i> 2007; <b>28</b>(1): 1–6. <a target=xrefwindow id=d23073e2496 href="http://www.ncbi.nlm.nih.gov/pubmed/17261360">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2499 href="http://dx.doi.org/10.1016/j.jaut.2006.12.004">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/722044917"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2508 class=n-a></a>Brix TH, Hegedüs L: Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. <i>Clin Endocrinol (Oxf).</i> 2012; <b>76</b>(4): 457–64. <a target=xrefwindow id=d23073e2516 href="http://www.ncbi.nlm.nih.gov/pubmed/22168537">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2519 href="http://dx.doi.org/10.1111/j.1365-2265.2011.04318.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/722044917">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d23073e2532 class=n-a></a>Bech K, Bliddal H, Feldt-Rasmussen U, <i> et al.</i>: Heterogeneity of autoimmune thyroiditis. <i>Allergy.</i> 1984; <b>39</b>(4): 239–47. <a target=xrefwindow id=d23073e2543 href="http://www.ncbi.nlm.nih.gov/pubmed/6375440">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2546 href="http://dx.doi.org/10.1111/j.1398-9995.1984.tb00861.x">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d23073e2556 class=n-a></a>DeGroot LJ: Diagnosis and Treatment of Graves’ Disease. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, <i>et al.</i>, editors. Endotext. South Dartmouth (MA); 2000. <a target=xrefwindow id=d23073e2561 href="http://www.ncbi.nlm.nih.gov/pubmed/25905403">PubMed Abstract </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d23073e2570 class=n-a></a>Vanderpump MP: The epidemiology of thyroid disease. <i>Br Med Bull.</i> 2011; <b>99</b>: 39–51. <a target=xrefwindow id=d23073e2578 href="http://www.ncbi.nlm.nih.gov/pubmed/21893493">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2581 href="http://dx.doi.org/10.1093/bmb/ldr030">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11857956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2590 class=n-a></a>Pedersen IB, Knudsen N, Carlé A, <i> et al.</i>: A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. <i>Clin Endocrinol (Oxf).</i> 2011; <b>75</b>(1): 120–6. <a target=xrefwindow id=d23073e2601 href="http://www.ncbi.nlm.nih.gov/pubmed/21521277">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2604 href="http://dx.doi.org/10.1111/j.1365-2265.2011.04008.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11857956">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d23073e2617 class=n-a></a>Jørgensen KT, Pedersen BV, Nielsen NM, <i> et al.</i>: Childbirths and risk of female predominant and other autoimmune diseases in a population-based Danish cohort. <i>J Autoimmun.</i> 2012; <b>38</b>(2–3): J81–7. <a target=xrefwindow id=d23073e2628 href="http://www.ncbi.nlm.nih.gov/pubmed/21813263">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2631 href="http://dx.doi.org/10.1016/j.jaut.2011.06.004">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d23073e2640 class=n-a></a>Hansen PS, Brix TH, Iachine I, <i> et al.</i>: The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: a study of healthy Danish twins. <i>Eur J Endocrinol.</i> 2006; <b>154</b>(1): 29–38. <a target=xrefwindow id=d23073e2651 href="http://www.ncbi.nlm.nih.gov/pubmed/16381988">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2654 href="http://dx.doi.org/10.1530/eje.1.02060">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d23073e2663 class=n-a></a>Pedersen IB, Knudsen N, Jørgensen T, <i> et al.</i>: Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. <i>Clin Endocrinol (Oxf).</i> 2003; <b>58</b>(1): 36–42. <a target=xrefwindow id=d23073e2674 href="http://www.ncbi.nlm.nih.gov/pubmed/12519410">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2677 href="http://dx.doi.org/10.1046/j.1365-2265.2003.01633.x">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d23073e2687 class=n-a></a>Rasmussen AK, Feldt-Rasmussen U, Brandt M, <i> et al.</i>: Thyrotropin stimulates specifically the expression of the autoantibody binding domains of the thyroperoxidase molecule. <i>Autoimmunity.</i> 1999; <b>29</b>(4): 323–31. <a target=xrefwindow id=d23073e2698 href="http://www.ncbi.nlm.nih.gov/pubmed/10433088">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2701 href="http://dx.doi.org/10.3109/08916939908994752">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727207631"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2710 class=n-a></a>Smith TJ, Hegedüs L: Graves' Disease. <i>N Engl J Med.</i> 2016; <b>375</b>: 1552–65. <a target=xrefwindow id=d23073e2718 href="http://www.ncbi.nlm.nih.gov/pubmed/27797318">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2721 href="http://dx.doi.org/10.1056/NEJMra1510030">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727207631">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d23073e2734 class=n-a></a>WITEBSKY E, ROSE NR, TERPLAN K, <i> et al.</i>: Chronic thyroiditis and autoimmunization. <i>J Am Med Assoc.</i> 1957; <b>164</b>(13): 1439–47. <a target=xrefwindow id=d23073e2745 href="http://www.ncbi.nlm.nih.gov/pubmed/13448890">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2748 href="http://dx.doi.org/10.1001/jama.1957.02980130015004">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d23073e2757 class=n-a></a>Rose NR: Autoimmune diseases: tracing the shared threads. <i>Hosp Pract (1995).</i> 1997; <b>32</b>(4): 147–54. <a target=xrefwindow id=d23073e2765 href="http://www.ncbi.nlm.nih.gov/pubmed/9109812">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2768 href="http://dx.doi.org/10.1080/21548331.1997.11443469">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d23073e2777 class=n-a></a>Sheehan NJ, Stanton-King K: Polyautoimmunity in a young woman. <i>Br J Rheumatol.</i> 1993; <b>32</b>(3): 254–6. <a target=xrefwindow id=d23073e2785 href="http://www.ncbi.nlm.nih.gov/pubmed/8448621">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2788 href="http://dx.doi.org/10.1093/rheumatology/32.3.254">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d23073e2797 class=n-a></a>Anaya JM, Castiblanco J, Rojas-Villarraga A, <i> et al.</i>: The multiple autoimmune syndromes. A clue for the autoimmune tautology. <i>Clin Rev Allergy Immunol.</i> 2012; <b>43</b>(3): 256–64. <a target=xrefwindow id=d23073e2808 href="http://www.ncbi.nlm.nih.gov/pubmed/22648455">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2811 href="http://dx.doi.org/10.1007/s12016-012-8317-z">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d23073e2821 class=n-a></a>Humbert P, Dupond JL: [Multiple autoimmune syndromes]. <i>Ann Med Interne (Paris).</i> 1988; <b>139</b>(3): 159–68. <a target=xrefwindow id=d23073e2829 href="http://www.ncbi.nlm.nih.gov/pubmed/3059902">PubMed Abstract </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d23073e2838 class=n-a></a>Eisenbarth GS, Gottlieb PA: Autoimmune polyendocrine syndromes. <i>N Engl J Med.</i> 2004; <b>350</b>(20): 2068–79. <a target=xrefwindow id=d23073e2846 href="http://www.ncbi.nlm.nih.gov/pubmed/15141045">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2849 href="http://dx.doi.org/10.1056/NEJMra030158">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d23073e2858 class=n-a></a>Halonen M, Eskelin P, Myhre AG, <i> et al.</i>: AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. <i>J Clin Endocrinol Metab.</i> 2002; <b>87</b>(6): 2568–74. <a target=xrefwindow id=d23073e2869 href="http://www.ncbi.nlm.nih.gov/pubmed/12050215">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2872 href="http://dx.doi.org/10.1210/jcem.87.6.8564">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d23073e2881 class=n-a></a>Myhre AG, Undlien DE, Løvås K, <i> et al.</i>: Autoimmune adrenocortical failure in Norway autoantibodies and human leukocyte antigen class II associations related to clinical features. <i>J Clin Endocrinol Metab.</i> 2002; <b>87</b>(2): 618–23. <a target=xrefwindow id=d23073e2892 href="http://www.ncbi.nlm.nih.gov/pubmed/11836294">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2895 href="http://dx.doi.org/10.1210/jcem.87.2.8192">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d23073e2904 class=n-a></a>Mackay IR: Clustering and commonalities among autoimmune diseases. <i>J Autoimmun.</i> 2009; <b>33</b>(3–4): 170–7. <a target=xrefwindow id=d23073e2912 href="http://www.ncbi.nlm.nih.gov/pubmed/19837564">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2915 href="http://dx.doi.org/10.1016/j.jaut.2009.09.006">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d23073e2924 class=n-a></a>Zeher M, Horvath IF, Szanto A, <i> et al.</i>: Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome. <i>Thyroid.</i> 2009; <b>19</b>(1): 39–45. <a target=xrefwindow id=d23073e2935 href="http://www.ncbi.nlm.nih.gov/pubmed/19119981">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2938 href="http://dx.doi.org/10.1089/thy.2007.0398">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d23073e2948 class=n-a></a>Biró E, Szekanecz Z, Czirják L, <i> et al.</i>: Association of systemic and thyroid autoimmune diseases. <i>Clin Rheumatol.</i> 2006; <b>25</b>(2): 240–5. <a target=xrefwindow id=d23073e2959 href="http://www.ncbi.nlm.nih.gov/pubmed/16247581">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2962 href="http://dx.doi.org/10.1007/s10067-005-1165-y">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720389759"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e2971 class=n-a></a>Nakamura H, Usa T, Motomura M, <i> et al.</i>: Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. <i>J Endocrinol Invest.</i> 2008; <b>31</b>(10): 861–5. <a target=xrefwindow id=d23073e2982 href="http://www.ncbi.nlm.nih.gov/pubmed/19092289">PubMed Abstract </a> | <a target=xrefwindow id=d23073e2985 href="http://dx.doi.org/10.1007/BF03346432">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720389759">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d23073e2998 class=n-a></a>Liao KP, Kurreeman F, Li G, <i> et al.</i>: Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls. <i>Arthritis Rheum.</i> 2013; <b>65</b>(3): 571–81. <a target=xrefwindow id=d23073e3009 href="http://www.ncbi.nlm.nih.gov/pubmed/23233247">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3012 href="http://dx.doi.org/10.1002/art.37801">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3016 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3582761">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d23073e3025 class=n-a></a>Feldt-Rasmussen U, Høier-Madsen M, Bech K, <i> et al.</i>: Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. <i>Autoimmunity.</i> 1991; <b>9</b>(3): 245–54. <a target=xrefwindow id=d23073e3036 href="http://www.ncbi.nlm.nih.gov/pubmed/1777557">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3039 href="http://dx.doi.org/10.3109/08916939109007650">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727096475"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3048 class=n-a></a>Fallahi P, Ferrari SM, Ruffilli I, <i> et al.</i>: The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients. <i>Autoimmun Rev.</i> 2016; <b>15</b>(12): 1125–8. <a target=xrefwindow id=d23073e3059 href="http://www.ncbi.nlm.nih.gov/pubmed/27639841">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3062 href="http://dx.doi.org/10.1016/j.autrev.2016.09.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727096475">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d23073e3075 class=n-a></a>Di Mario U, Perfetti R, Anastasi E, <i> et al.</i>: Autoantibodies to insulin do appear in non-diabetic patients with autoimmune disorders: comparison with anti-immunoglobulin antibodies and other autoimmune phenomena. <i>Acta Endocrinol (Copenh).</i> 1990; <b>122</b>(3): 303–8. <a target=xrefwindow id=d23073e3086 href="http://www.ncbi.nlm.nih.gov/pubmed/2183533">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3089 href="http://dx.doi.org/10.1530/acta.0.1220303">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725053564"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3099 class=n-a></a>Boelaert K, Newby PR, Simmonds MJ, <i> et al.</i>: Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. <i>Am J Med.</i> 2010; <b>123</b>(2): 183.e1–9. <a target=xrefwindow id=d23073e3110 href="http://www.ncbi.nlm.nih.gov/pubmed/20103030">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3113 href="http://dx.doi.org/10.1016/j.amjmed.2009.06.030">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725053564">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d23073e3126 class=n-a></a>Wiebolt J, Achterbergh R, den Boer A, <i> et al.</i>: Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients. <i>Eur J Endocrinol.</i> 2011; <b>164</b>(5): 789–94. <a target=xrefwindow id=d23073e3137 href="http://www.ncbi.nlm.nih.gov/pubmed/21378091">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3140 href="http://dx.doi.org/10.1530/EJE-10-1172">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d23073e3149 class=n-a></a>Eaton WW, Pedersen MG, Atladóttir HO, <i> et al.</i>: The prevalence of 30 ICD-10 autoimmune diseases in Denmark. <i>Immunol Res.</i> 2010; <b>47</b>(1–3): 228–31. <a target=xrefwindow id=d23073e3160 href="http://www.ncbi.nlm.nih.gov/pubmed/20066507">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3163 href="http://dx.doi.org/10.1007/s12026-009-8153-2">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3167 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2892249">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d23073e3176 class=n-a></a>Eaton WW, Rose NR, Kalaydjian A, <i> et al.</i>: Epidemiology of autoimmune diseases in Denmark. <i>J Autoimmun.</i> 2007; <b>29</b>(1): 1–9. <a target=xrefwindow id=d23073e3187 href="http://www.ncbi.nlm.nih.gov/pubmed/17582741">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3190 href="http://dx.doi.org/10.1016/j.jaut.2007.05.002">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3194 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2717015">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d23073e3203 class=n-a></a>Somers EC, Thomas SL, Smeeth L, <i> et al.</i>: Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? <i>Am J Epidemiol.</i> 2009; <b>169</b>(6): 749–55. <a target=xrefwindow id=d23073e3214 href="http://www.ncbi.nlm.nih.gov/pubmed/19224981">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3217 href="http://dx.doi.org/10.1093/aje/kwn408">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d23073e3226 class=n-a></a>Ottesen M, Feldt-Rasmussen U, Andersen J, <i> et al.</i>: Thyroid function and autoimmunity in pernicious anemia before and during cyanocobalamin treatment. <i>J Endocrinol Invest.</i> 1995; <b>18</b>(2): 91–7. <a target=xrefwindow id=d23073e3237 href="http://www.ncbi.nlm.nih.gov/pubmed/7629393">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3240 href="http://dx.doi.org/10.1007/BF03349707">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d23073e3250 class=n-a></a>Anaya JM: The diagnosis and clinical significance of polyautoimmunity. <i>Autoimmun Rev.</i> 2014; <b>13</b>(4–5): 423–6. <a target=xrefwindow id=d23073e3258 href="http://www.ncbi.nlm.nih.gov/pubmed/24424171">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3261 href="http://dx.doi.org/10.1016/j.autrev.2014.01.049">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d23073e3270 class=n-a></a>Raterman HG, Voskuyl AE, Simsek S, <i> et al.</i>: Increased progression of carotid intima media thickness in thyroid peroxidase antibodies-positive rheumatoid arthritis patients. <i>Eur J Endocrinol.</i> 2013; <b>169</b>(6): 751–7. <a target=xrefwindow id=d23073e3281 href="http://www.ncbi.nlm.nih.gov/pubmed/24005313">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3284 href="http://dx.doi.org/10.1530/EJE-13-0394">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d23073e3293 class=n-a></a>Willeit P, Thompson SG, Agewall S, <i> et al.</i>: Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration. <i>Eur J Prev Cardiol.</i> 2016; <b>23</b>(2): 194–205. <a target=xrefwindow id=d23073e3304 href="http://www.ncbi.nlm.nih.gov/pubmed/25416041">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3307 href="http://dx.doi.org/10.1177/2047487314560664">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3311 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4544641">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d23073e3320 class=n-a></a>Caforio AL, Wagner R, Gill JS, <i> et al.</i>: Organ-specific cardiac antibodies: serological markers for systemic hypertension in autoimmune polyendocrinopathy. <i>Lancet.</i> 1991; <b>337</b>(8750): 1111–5. <a target=xrefwindow id=d23073e3331 href="http://www.ncbi.nlm.nih.gov/pubmed/1674011">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3334 href="http://dx.doi.org/10.1016/0140-6736(91)92784-Y">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d23073e3343 class=n-a></a>de Jesus GR, Agmon-Levin N, Andrade CA, <i> et al.</i>: 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. <i>Autoimmun Rev.</i> 2014; <b>13</b>(8): 795–813. <a target=xrefwindow id=d23073e3354 href="http://www.ncbi.nlm.nih.gov/pubmed/24650941">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3357 href="http://dx.doi.org/10.1016/j.autrev.2014.02.003">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d23073e3366 class=n-a></a>Chen LM, Zhang Q, Si GX, <i> et al.</i>: Associations between thyroid autoantibody status and abnormal pregnancy outcomes in euthyroid women. <i>Endocrine.</i> 2015; <b>48</b>(3): 924–8. <a target=xrefwindow id=d23073e3377 href="http://www.ncbi.nlm.nih.gov/pubmed/25209893">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3380 href="http://dx.doi.org/10.1007/s12020-014-0420-x">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11083960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3390 class=n-a></a>Thangaratinam S, Tan A, Knox E, <i> et al.</i>: Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. <i>BMJ.</i> 2011; <b>342</b>: d2616. <a target=xrefwindow id=d23073e3401 href="http://www.ncbi.nlm.nih.gov/pubmed/21558126">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3404 href="http://dx.doi.org/10.1136/bmj.d2616">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3408 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3089879">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11083960">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724596018"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3421 class=n-a></a>Iijima T, Tada H, Hidaka Y, <i> et al.</i>: Effects of autoantibodies on the course of pregnancy and fetal growth. <i>Obstet Gynecol.</i> 1997; <b>90</b>(3): 364–9. <a target=xrefwindow id=d23073e3432 href="http://www.ncbi.nlm.nih.gov/pubmed/9277645">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3435 href="http://dx.doi.org/10.1016/S0029-7844(97)00283-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724596018">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726139968"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3448 class=n-a></a>Mekinian A, Cohen J, Alijotas-Reig J, <i> et al.</i>: Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation? <i>Am J Reprod Immunol.</i> 2016; <b>76</b>(1): 8–28. <a target=xrefwindow id=d23073e3459 href="http://www.ncbi.nlm.nih.gov/pubmed/26847715">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3462 href="http://dx.doi.org/10.1111/aji.12493">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726139968">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d23073e3475 class=n-a></a>Piga M, Serra A, Deiana L, <i> et al.</i>: Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis. <i>Eur J Nucl Med Mol Imaging.</i> 2004; <b>31</b>(12): 1639–44. <a target=xrefwindow id=d23073e3486 href="http://www.ncbi.nlm.nih.gov/pubmed/15290119">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3489 href="http://dx.doi.org/10.1007/s00259-004-1625-7">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d23073e3498 class=n-a></a>Montagna G, Imperiali M, Agazzi P, <i> et al.</i>: Hashimoto's encephalopathy: A rare proteiform disorder. <i>Autoimmun Rev.</i> 2016; <b>15</b>(5): 466–76. <a target=xrefwindow id=d23073e3509 href="http://www.ncbi.nlm.nih.gov/pubmed/26849953">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3512 href="http://dx.doi.org/10.1016/j.autrev.2016.01.014">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d23073e3521 class=n-a></a>Watt T, Hegedü s L, Bjorner JB, <i> et al.</i>: Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism? <i>Eur Thyroid J.</i> 2012; <b>1</b>(3): 186–92. <a target=xrefwindow id=d23073e3532 href="http://www.ncbi.nlm.nih.gov/pubmed/24783018">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3535 href="http://dx.doi.org/10.1159/000342623">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3539 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3821477">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d23073e3549 class=n-a></a>Bové KB, Watt T, Vogel A, <i> et al.</i>: Anxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre. <i>Eur Thyroid J.</i> 2014; <b>3</b>(3): 173–8. <a target=xrefwindow id=d23073e3560 href="http://www.ncbi.nlm.nih.gov/pubmed/25538899">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3563 href="http://dx.doi.org/10.1159/000365211">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3567 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4224229">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d23073e3576 class=n-a></a>Avouac J, Airò P, Dieude P, <i> et al.</i>: Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients. <i>J Rheumatol.</i> 2010; <b>37</b>(3): 608–14. <a target=xrefwindow id=d23073e3587 href="http://www.ncbi.nlm.nih.gov/pubmed/20110522">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3590 href="http://dx.doi.org/10.3899/jrheum.090815">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d23073e3599 class=n-a></a>Marinó M, Ricciardi R, Pinchera A, <i> et al.</i>: Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. <i>J Clin Endocrinol Metab.</i> 1997; <b>82</b>(2): 438–43. <a target=xrefwindow id=d23073e3610 href="http://www.ncbi.nlm.nih.gov/pubmed/9024233">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3613 href="http://dx.doi.org/10.1210/jcem.82.2.3749">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d23073e3622 class=n-a></a>Wiersinga WM, Duntas L, Fadeyev V, <i> et al.</i>: 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. <i>Eur Thyroid J.</i> 2012; <b>1</b>(2): 55–71. <a target=xrefwindow id=d23073e3633 href="http://www.ncbi.nlm.nih.gov/pubmed/24782999">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3636 href="http://dx.doi.org/10.1159/000339444">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3640 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3821467">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d23073e3649 class=n-a></a>Coles AJ, Wing M, Smith S, <i> et al.</i>: Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. <i>Lancet.</i> 1999; <b>354</b>(9191): 1691–5. <a target=xrefwindow id=d23073e3660 href="http://www.ncbi.nlm.nih.gov/pubmed/10568572">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3663 href="http://dx.doi.org/10.1016/S0140-6736(99)02429-0">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d23073e3672 class=n-a></a>Mandac JC, Chaudhry S, Sherman KE, <i> et al.</i>: The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. <i>Hepatology.</i> 2006; <b>43</b>(4): 661–72. <a target=xrefwindow id=d23073e3683 href="http://www.ncbi.nlm.nih.gov/pubmed/16557537">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3686 href="http://dx.doi.org/10.1002/hep.21146">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d23073e3696 class=n-a></a>Antonelli A, Ferri C, Fallahi P: Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy. <i>Nat Rev Gastroenterol Hepatol.</i> 2009; <b>6</b>(11): 633–5. <a target=xrefwindow id=d23073e3704 href="http://www.ncbi.nlm.nih.gov/pubmed/19881515">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3707 href="http://dx.doi.org/10.1038/nrgastro.2009.168">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d23073e3716 class=n-a></a>Stefan M, Jacobson EM, Huber AK, <i> et al.</i>: Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. <i>J Biol Chem.</i> 2011; <b>286</b>(36): 31168–79. <a target=xrefwindow id=d23073e3727 href="http://www.ncbi.nlm.nih.gov/pubmed/21757724">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3730 href="http://dx.doi.org/10.1074/jbc.M111.247510">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3734 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3173071">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726146507"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3743 class=n-a></a>Spain L, Diem S, Larkin J: Management of toxicities of immune checkpoint inhibitors. <i>Cancer Treat Rev.</i> 2016; <b>44</b>: 51–60. <a target=xrefwindow id=d23073e3751 href="http://www.ncbi.nlm.nih.gov/pubmed/26874776">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3754 href="http://dx.doi.org/10.1016/j.ctrv.2016.02.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726146507">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d23073e3767 class=n-a></a>Corsello SM, Barnabei A, Marchetti P, <i> et al.</i>: Endocrine side effects induced by immune checkpoint inhibitors. <i>J Clin Endocrinol Metab.</i> 2013; <b>98</b>(4): 1361–75. <a target=xrefwindow id=d23073e3778 href="http://www.ncbi.nlm.nih.gov/pubmed/23471977">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3781 href="http://dx.doi.org/10.1210/jc.2012-4075">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d23073e3790 class=n-a></a>Bliddal S, Borresen SW, Feldt-Rasmussen U: Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis. <i>Front Endocrinol (Lausanne).</i> 2017; <b>8</b>: 179. <a target=xrefwindow id=d23073e3798 href="http://www.ncbi.nlm.nih.gov/pubmed/28824542">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3801 href="http://dx.doi.org/10.3389/fendo.2017.00179">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3804 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5534470">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d23073e3813 class=n-a></a>Raterman HG, Jamnitski A, Lems WF, <i> et al.</i>: Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. <i>J Rheumatol.</i> 2011; <b>38</b>(2): 247–51. <a target=xrefwindow id=d23073e3824 href="http://www.ncbi.nlm.nih.gov/pubmed/21078720">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3827 href="http://dx.doi.org/10.3899/jrheum.100488">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d23073e3837 class=n-a></a>El Fassi D, Nielsen CH, Hasselbalch HC, <i> et al.</i>: Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion. <i>Thyroid.</i> 2006; <b>16</b>(7): 709–10. <a target=xrefwindow id=d23073e3848 href="http://www.ncbi.nlm.nih.gov/pubmed/16889501">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3851 href="http://dx.doi.org/10.1089/thy.2006.16.709">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d23073e3860 class=n-a></a>Nielsen CH, El Fassi D, Hasselbalch HC, <i> et al.</i>: B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family. <i>Expert Opin Biol Ther.</i> 2007; <b>7</b>(7): 1061–78. <a target=xrefwindow id=d23073e3871 href="http://www.ncbi.nlm.nih.gov/pubmed/17665994">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3874 href="http://dx.doi.org/10.1517/14712598.7.7.1061">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725276554"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3883 class=n-a></a>Salvi M, Vannucchi G, Currò N, <i> et al.</i>: Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study. <i>J Clin Endocrinol Metab.</i> 2015; <b>100</b>(2): 422–31. <a target=xrefwindow id=d23073e3894 href="http://www.ncbi.nlm.nih.gov/pubmed/25494967">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3897 href="http://dx.doi.org/10.1210/jc.2014-3014">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3901 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4318899">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725276554">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d23073e3914 class=n-a></a>Buch MH, Smolen JS, Betteridge N, <i> et al.</i>: Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. <i>Ann Rheum Dis.</i> 2011; <b>70</b>(6): 909–20. <a target=xrefwindow id=d23073e3925 href="http://www.ncbi.nlm.nih.gov/pubmed/21378402">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3928 href="http://dx.doi.org/10.1136/ard.2010.144998">Publisher Full Text </a> | <a target=xrefwindow id=d23073e3932 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3086093">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1104283"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3941 class=n-a></a>Hauser SL, Waubant E, Arnold DL, <i> et al.</i>: B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. <i>N Engl J Med.</i> 2008; <b>358</b>(7): 676–88. <a target=xrefwindow id=d23073e3952 href="http://www.ncbi.nlm.nih.gov/pubmed/18272891">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3955 href="http://dx.doi.org/10.1056/NEJMoa0706383">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1104283">F1000 Recommendation</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1279979"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3968 class=n-a></a>Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, <i> et al.</i>: Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. <i>N Engl J Med.</i> 2009; <b>361</b>(22): 2143–52. <a target=xrefwindow id=d23073e3979 href="http://www.ncbi.nlm.nih.gov/pubmed/19940299">PubMed Abstract </a> | <a target=xrefwindow id=d23073e3982 href="http://dx.doi.org/10.1056/NEJMoa0904452">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1279979">F1000 Recommendation</a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727577398"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e3996 class=n-a></a>Smith TJ, Kahaly GJ, Ezra DG, <i> et al.</i>: Teprotumumab for Thyroid-Associated Ophthalmopathy. <i>N Engl J Med.</i> 2017; <b>376</b>(18): 1748–61. <a target=xrefwindow id=d23073e4007 href="http://www.ncbi.nlm.nih.gov/pubmed/28467880">PubMed Abstract </a> | <a target=xrefwindow id=d23073e4010 href="http://dx.doi.org/10.1056/NEJMoa1614949">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727577398">F1000 Recommendation</a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727869572"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d23073e4023 class=n-a></a>Baker KF, Isaacs JD: Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis? <i>Ann Rheum Dis.</i> 2017; pii: annrheumdis-2017-211555. <a target=xrefwindow id=d23073e4028 href="http://www.ncbi.nlm.nih.gov/pubmed/28765121">PubMed Abstract </a> | <a target=xrefwindow id=d23073e4031 href="http://dx.doi.org/10.1136/annrheumdis-2017-211555">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727869572">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1776.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1776.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medical Endocrinology, Section 2132, Copenhagen University Hospital (Rigshospitalet), Blegdamsvej 9, 2100 Copenhagen, Denmark<br/> <sup>2</sup> Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, section 7521, Copenhagen University Hospital (Rigshospitalet), Blegdamsvej 9, 2100 Copenhagen, Denmark<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1776/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 28 Sep 2017, 6:1776 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11535.1">https://doi.org/10.12688/f1000research.11535.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Bliddal S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12459 data-id=11535 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11535.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1776/v1/pdf?article_uuid=990f859d-ada4-4be7-a689-798b88c62989" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11535.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Bliddal S, Nielsen CH and Feldt-Rasmussen U. Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1776 (<a href="https://doi.org/10.12688/f1000research.11535.1" target=_blank>https://doi.org/10.12688/f1000research.11535.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11535 id=mobile-track-article-signin-11535 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11535?target=/articles/6-1776.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12459 /> <input name=articleId type=hidden value=11535 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Maria Marazuela</strong>, Service of Endocrinology, Hospital Universitario de la Princesa, Instituto de Investigacion Princesa, Universidad Autónoma de Madrid, Spain </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Alessandro Antonelli</strong>, Department of Clinical and Experimental Medicine, University of Pisa, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1776.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1776.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23965-26164></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=26302-26165></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1776/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>28 Sep 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Maria Marazuela</strong>, Service of Endocrinology, Hospital Universitario de la Princesa, Instituto de Investigacion Princesa, Universidad Autónoma de Madrid, Spain </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Alessandro Antonelli</strong>, Department of Clinical and Experimental Medicine, University of Pisa, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1776.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1776/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding autoimmune...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1776/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1776/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1776/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Bliddal S et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1776/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1776",
            templates : {
                twitter : "Recent advances in understanding autoimmune thyroid disease:.... Bliddal S et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1776/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11535/12459")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12459");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "26164": 0,
                           "26165": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "6fcc93f8-0c97-4676-a152-e9da2b3bf7be";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1776.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1776.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1776.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1776.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1776.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>